BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 25318545)

  • 1. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
    Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
    J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Guo Y; Zhao Y; Nan Y; Wang X; Chen Y; Wang S
    Neuroreport; 2017 Jul; 28(10):590-597. PubMed ID: 28520620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
    Yang H; Yang H; Xie Z; Wang P; Bi J
    Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice.
    Rezai-Zadeh K; Arendash GW; Hou H; Fernandez F; Jensen M; Runfeldt M; Shytle RD; Tan J
    Brain Res; 2008 Jun; 1214():177-87. PubMed ID: 18457818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
    Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
    J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icariin, a phosphodiesterase-5 inhibitor, improves learning and memory in APP/PS1 transgenic mice by stimulation of NO/cGMP signalling.
    Jin F; Gong QH; Xu YS; Wang LN; Jin H; Li F; Li LS; Ma YM; Shi JS
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):871-81. PubMed ID: 24513083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary supplementation of walnuts improves memory deficits and learning skills in transgenic mouse model of Alzheimer's disease.
    Muthaiyah B; Essa MM; Lee M; Chauhan V; Kaur K; Chauhan A
    J Alzheimers Dis; 2014; 42(4):1397-405. PubMed ID: 25024344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea epigallocatechin-3-gallate (EGCG) and other flavonoids reduce Alzheimer's amyloid-induced mitochondrial dysfunction.
    Dragicevic N; Smith A; Lin X; Yuan F; Copes N; Delic V; Tan J; Cao C; Shytle RD; Bradshaw PC
    J Alzheimers Dis; 2011; 26(3):507-21. PubMed ID: 21694462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
    J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
    Jia N; Han K; Kong JJ; Zhang XM; Sha S; Ren GR; Cao YP
    Mol Cell Biochem; 2013 Aug; 380(1-2):211-8. PubMed ID: 23660953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing.
    Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY
    J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
    Nan S; Wang P; Zhang Y; Fan J
    Drug Des Devel Ther; 2021; 15():2013-2024. PubMed ID: 34012254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icariin decreases both APP and Aβ levels and increases neurogenesis in the brain of Tg2576 mice.
    Li F; Dong HX; Gong QH; Wu Q; Jin F; Shi JS
    Neuroscience; 2015 Sep; 304():29-35. PubMed ID: 26079110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research on EGCG improving the degenerative changes of the brain in AD model mice induced with chemical drugs].
    He M; Liu MY; Wang S; Tang QS; Yao WF; Zhao HS; Wei MJ
    Zhong Yao Cai; 2012 Oct; 35(10):1641-4. PubMed ID: 23627134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease.
    Edwards SR; Hamlin AS; Marks N; Coulson EJ; Smith MT
    Clin Exp Pharmacol Physiol; 2014 Oct; 41(10):798-806. PubMed ID: 25115283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.